Analyst firms · Morgan Stanley · CVS

Morgan Stanley CVS price target and rating history

CVS Health Corporation (CVS) · Consumer Staples

Morgan Stanley rates CVS Health Corporation (CVS) Overweight with a $119 price target, as of its latest action on Nov 23, 2022. It has published 4 rating actions on CVS since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Overweight
Price target
$119
Median target, all firms
Too few
Actions on CVS
4

Morgan Stanley price target on CVS

$125$120$11420222023202420252026
Morgan Stanley price target on CVS, each point a stated target, August 2021 to November 2022.

Every Morgan Stanley rating on CVS

Questions about Morgan Stanley and CVS

What is Morgan Stanley's price target for CVS?
Morgan Stanley's latest stated price target for CVS Health Corporation (CVS) is $119, from its action on Nov 23, 2022.
What is Morgan Stanley's rating on CVS?
Morgan Stanley rates CVS Overweight, a bullish rating, as of Nov 23, 2022.
When did Morgan Stanley last change its view on CVS?
On Nov 23, 2022, Morgan Stanley resumes coverage at Overweight, price target $124 to $119.

More CVS rating histories

All Morgan Stanley ratingsCVS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.